NovaBiotics Ltd
Cruickshank Building
Craibstone
Aberdeen
AB21 9TR
UK
NovaBiotics believes that our continued success is dependent on creating a sustainably innovative culture within the business. Our staff, the environment and the community are central to this and therefore components of the Company’s core operational values.

Safety, regulation & the environment
As a minimum, we will meet or exceed all relevant legislation as we carry out the research (and administrative) tasks required to deliver the Company’s drug design and development plans. Where no legislation exists, appropriate internal standards (benchmarked against and beyond best practices elsewhere) have been developed and implemented and are components of a fully auditable quality management and policy system. NovaBiotics is fully committed to minimising any impact its operational activities might have on the environment and through ongoing internal review and external audits actively looks for opportunities to improve its activities wherever possible.

Education & the Community
NovaBiotics is actively engaged in a number of programmes promoting biomedical research and commercial-academic links with both of Aberdeen’s universities (and some further afield). We are also delighted to continue to participate as hosts and sponsors in both the Nuffield Foundation and Crest Science Award schemes for secondary schools. Through our links with local Academies, we promote the science career opportunities available to local pupils; both through site visits to NovaBiotics and science clubs within schools. We remain passionate about developing the next generation of local science talent in what is a key, emerging employment sector in the North East of Scotland.
NovaBiotics shall be taking part in TechFest In September 2011 which is Aberdeen and the North East of Scotland’s annual festival of Science, Technology, Engineering and Mathematics (STEM).
Latest News
17th June 2011
NovaBiotics selected to present at BIO 2011
24th May 2011
NovaBiotics shall be attending BioDundee on 8th and 9th June 2011
3rd May 2011
NovaBiotics featured in IMS Drug news
31st March 2011
NovaBiotics shall be attending BioTrinity 2011 from 12th - 14th April 2011
28th March 2011
NovaBiotics are attending the UK-Netherlands Joint Symposium on Antimicrobial Peptides in Durham, UK
21st February 2011
December 2010
NovaBiotics attending Peptide Formulation and Product Development Forum
November 2010
NovaBiotics Selected to present at Bio-Europe
September 2010
August 2010
NovaBiotics selected to present at ICAAC 2010
June 2010
NovaBiotic's Unblinded Phase IIa Novexatin® Data delivers excellent results
May 2010
NovaBiotics Successful Completion of Phase IIa clinical trial for Novexatin®